These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9949)

  • 1. Proceedings: Possible explanation for protective action of long-term beta-adrenoceptor blockade after myocardial infarction.
    Raine AE; Williams EM
    Br Heart J; 1976 Aug; 38(8):873-4. PubMed ID: 9949
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study of beta andreoceptor antagonists on the isolated atria of control and of the reserpine treated rabbits.
    Hague MA; Darabi MK; Khalighi MR
    Pahlavi Med J; 1977 Jul; 8(3):326-44. PubMed ID: 21372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the pA2 of various beta blocking agents].
    Spach MO; Miesch F; Schwartz J
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3221-2. PubMed ID: 3766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of racemic propranolol, dextro-propranolol and racemic practolol on the human and canine cardiac transmembrane action potential (beta blockade and the cardiac action potential).
    Coltart DJ; Meldrum SJ
    Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):188-97. PubMed ID: 4398411
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac and bronchial beta-adrenoceptor antagonistic potencies of atenolol, metoprolol, acebutolol, practolol, propranolol and pindolol in the anaesthetized dog.
    Harms HH; Spoelstra AJ
    Clin Exp Pharmacol Physiol; 1978; 5(1):53-9. PubMed ID: 25152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Pharmacological studies with LL 21-945, a new beta-adrenoceptor blocking agent with a long duration of action.
    Clark BJ; Saameli K; Troxler F
    Br J Pharmacol; 1974 Sep; 52(1):123P. PubMed ID: 4155983
    [No Abstract]   [Full Text] [Related]  

  • 7. [Editorial: Importance of cardioselectivity and sympaticomimetric potential of beta-blockers (author's transl)].
    Dubach UC
    Schweiz Rundsch Med Prax; 1975 Sep; 64(39):1239-41. PubMed ID: 241073
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac effects of beta-adrenergic receptor antagonists: beta-moderators versus beta-blockers.
    Dhalla NS; Alto LE; Pierce GN; Daly MJ; Dhillon KS; Compier R; Guerin A
    Clin Ther; 1980; 3(4):254-9. PubMed ID: 6115715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacology of acebutolol in animals].
    Basil B
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3217-21. PubMed ID: 1219628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels and beta-adrenoceptor blockade with acebutolol, practolol and propranolol in man.
    Cuthbert MF; Collins RF
    Br J Clin Pharmacol; 1975 Feb; 2(1):49-55. PubMed ID: 1234486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the actions of acebutolol, practolol and propranolol on calcium transport by heart microsomes and mitochondria.
    Dhalla NS; Lee SL
    Br J Pharmacol; 1976 Jun; 57(2):215-21. PubMed ID: 132977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental analysis of the cardiovascular effects of acebutolol, a drug with beta-adrenolytic activity].
    Marmo E; Rossi F; Lampa E; Chieppa S; Apolito A; Del Vecchio F
    Arch Sci Med (Torino); 1978; 135(1):57-78. PubMed ID: 25058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac beta-adrenoceptor blockade: the quest for selectivity.
    Barrett AM
    J Pharmacol; 1985; 16 Suppl 2():95-108. PubMed ID: 2867254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
    Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of the adrenergic drugs on the electrical responses of the rabbit isolated heart atrium.
    Smejkal V; Mironneau J; Ojeda C; Gargouil YM
    Physiol Bohemoslov; 1970; 19(1):19-22. PubMed ID: 4394505
    [No Abstract]   [Full Text] [Related]  

  • 16. Long term beta-adrenergic blockade reduces tyrosine hydroxylase and dopamine beta-hydroxylase activities in sympathetic ganglia.
    Raine AE; Chubb IW
    Nature; 1977 May; 267(5608):265-7. PubMed ID: 17075
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of blocking the beta-adrenergic receptors on ventricular diastole and on the systole of the left atrium in normal subjects. (Evaluation with the polygraphic method)].
    Vitale P; Mazza F; Jacono A
    Minerva Cardioangiol; 1971 Aug; 19(8):418-23. PubMed ID: 4397763
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct and beta adrenergic blocking actions of nadolol (SQ 11725) on electrophysiologic properties of isolated canine myocardium.
    Gibson JK; Gelband H; Bassett AL
    J Pharmacol Exp Ther; 1977 Sep; 202(3):702-10. PubMed ID: 19621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of beta-adrenoceptor antagonists on spontaneous rate and on force of contraction of isolated rabbit atria.
    Singh KP
    Indian J Physiol Pharmacol; 1983; 27(4):311-6. PubMed ID: 6146567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D; Kawada T; Takeda K; Imai S
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.